Plasma atrial natriuretic peptide in patients with Graves' disease.
In order to clarify the effect of thyroid hormone on the plasma atrial natriuretic peptide (ANP) concentration, 14 patients with Graves' disease and 6 normal control subjects were studied. They were all under constant sodium intake because dietary sodium is known to affect the amount of plasma ANP. Sodium intake remained constant at 171 mEq daily for five consecutive days at which time the ANP concentration was measured. Graves' disease patients were tested both before and after surgery. The preoperative, hyperthyroid ANP level concentration in Graves' disease patients was 6.7 +/- 2.3 fmol/ml compared to a significantly lower level of 4.2 +/- 1.4 fmol/in normal control subjects. Seven days after surgery when Graves' disease patients became euthyroid their ANP markedly decreased to 4.2 +/- 2.9 fmol/ml. In the present study we were able to confirm that under a constant sodium diet, high plasma ANP in patients with Graves' disease was reduced after surgery when they became euthyroid. Results also suggest that high circulating ANP might play an important role in sodium and water metabolism and hemodynamic changes in hyperthyroidism.
Tajiri
J
J
Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan.
Noguchi
S
S
Naomi
S
S
Murakami
T
T
Morita
M
M
Murakami
N
N
Kato
R
R
Umeda
T
T
Sato
T
T
D000367:Age Factors; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D001794:Blood Pressure; D003404:Creatinine / Q000652:urine; D005260:Female; D006111:Graves Disease / Q000378:metabolism* / Q000601:surgery; D006339:Heart Rate; D006801:Humans; D008297:Male; D011863:Radioimmunoassay; D012964:Sodium / Q000652:urine; D013961:Thyroid Gland / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism; D013974:Thyroxine / Q000378:metabolism; D014284:Triiodothyronine / Q000378:metabolism
D014284:Triiodothyronine; D009320:Atrial Natriuretic Factor; D013972:Thyrotropin; D012964:Sodium; D003404:Creatinine; D013974:Thyroxine